Predicting Driving Ability in Alzheimer\u27s Disease Patients. by O\u27jile, Judith Rosemary
Louisiana State University
LSU Digital Commons
LSU Historical Dissertations and Theses Graduate School
1998
Predicting Driving Ability in Alzheimer's Disease
Patients.
Judith Rosemary O'jile
Louisiana State University and Agricultural & Mechanical College
Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_disstheses
This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in
LSU Historical Dissertations and Theses by an authorized administrator of LSU Digital Commons. For more information, please contact
gradetd@lsu.edu.
Recommended Citation




This manuscript has been reproduced from the microfilm master. UMI 
films the text directly from the original or copy submitted. Thus, some 
thesis and dissertation copies are in typewriter face, while others may be 
from any type of computer printer.
The quality of this reproduction is dependent upon the quality of the 
copy submitted. Broken or indistinct print, colored or poor quality 
illustrations and photographs, print bleedthrough, substandard margins, 
and improper alignment can adversely afreet reproduction.
In the unlikely event that the author did not send UMI a complete 
manuscript and there are missing pages, these will be noted. Also, if 
unauthorized copyright material had to be removed, a note will indicate 
the deletion.
Oversize materials (e.g., maps, drawings, charts) are reproduced by 
sectioning the original, beginning at the upper left-hand comer and 
continuing from left to right in equal sections with small overlaps. Each 
original is also photographed in one exposure and is included in reduced 
form at the back of the book.
Photographs included in the original manuscript have been reproduced 
xerographically in this copy. Higher quality 6” x 9” black and white 
photographic prints are available for any photographs or illustrations 
appearing in this copy for an additional charge. Contact UMI directly to 
order.
UMI
A Bell & Howell Information Company 
300 North Zeeb Road, Ann Arbor MI 48106-1346 USA 
313/761-4700 800/521-0600
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
PREDICTING DRIVING ABILITY IN ALZHEIMER'S DISEASE PATIENTS
A Dissertation
Submitted to the Graduate Faculty of the 
Louisiana State University and 
Agricultural and Mechanical College 
in partial fulfillment of the 
requirements for the degree of 
Doctor of Philosophy
i n
The Department of Psychology
by
Judith Rosemary O'Jile 
B.S., Georgia State University, 1990 
M.A., Louisiana State University, 1994 
May, 1998
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
UMI Num ber: 9 8 2 4 4 9 3
UMI Microform 9824493 
Copyright 1998, by UMI Company. All rights reserved.
This microform edition is protected against unauthorized 
copying under Title 17, United States Code.
UMI
300 North Zeeb Road 
Ann Arbor, MI 48103
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
A cknow ledgm ents
I would like to thank my committee members for their help with this 
project. I would especially like to thank Dr. Wm. Drew Gouvier. Throughout 
the years since I met him, he has been a mentor and a friend and was always 
willing to help me with any problems I may have had.
I would also like to thank the people who have helped me gather my
data, and this includes Mark Todd, Robert Santulli, James Pinkston, and 
Michael Santamaria. I have been fortunate in having many people who 
supported my work in less obvious ways, but not any less important. I would 
like to acknowledge the support I've received from my closest friends. Dawn 
Haptonstahl, Judith Levy, and Laurie Ryan.
I would particularly like to acknowledge the help I’ve received from 
my fianc6, Brendan Mongey, who has alternately praised and chastised me,
but supported me and always gave me the encouragement I needed.
ii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table of Contents
A c k n o w le d g e m e n ts .............................................................................................................. i i
List of Tables............................................................................................................................v
A b s t r a c t  v i
In t r o d u c t io n ............................................................................................................................I
Review of the Literature.................................................................................................... 3
Alzheim er's Disease................................................................................................ 3
P r e v a le n c e ................................................................................................................. 3
Description of the D isease.................................................................................... 4
General Characteristics and D iagnosis................................................. 4
Pathophysiological C hanges................................................................ 5
Other C haracteristics...............................................................................7
Etiology of AD........................................................................................................... 10
Genetic Basis................................................................................................ 10
Transmissible Agent T heory .............................................................. 12
Environmental Toxin Theory................................................................ 12
Abnormal Protein Theory......................................................................12
A cetylcholine T heory..............................................................................13
Inflam m ation T h eo ry ............................................................................. 14
Other Theories............................................................................................. 14
S u m m ary ....................................................................................................... 15
The Controversy Regarding Drivers with Alzheimer's Disease.......... 15
Factors Involved in D riving...............................................................................19
Restriction of D riving.......................................................................................... 22
Empirical Studies of Alzheimer’s Disease and Driving........................... 22
Consideration of Previously Used M ethologies.......................................... 26
Rationale for Study................................................................................................. 27
Research Questions and H ypotheses...............................................................30
M e th o d ...................................................................................................................................... 32
S u b jec ts ....................................................................................................................... 32
M easu res ..................................................................................................................... 33
D em ographic/D riving H istory Q uestionna ire ..............................33
Mini-Mental State Exam (MMSE)...........................................................33
Trail Making T est.......................................................................................34
Boston Naming T est.................................................................................. 35
Wechsler Memory Scale-Revised: Logical M em ory.................... 35
Wechsler Memory Scale-Revised: Visual Reproduction...............36
Category F luency....................................................................................... 36
Driver Performance Test........................................................................36
Driver Risk Index ...................................................................................... 37
P ro c e d u re ................................................................................................................... 37
iii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
R esu lts .................................................................................................................................... 40
Tests of Hypotheses................................................................................................. 40
Additional Analyses..............................................................................................44
D iscussion..............................................................................................................................5 1
R e fe re n c e s ........................................................................................................................... 59
V ita .......................................................................................................................................... 69
iv
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
List of Tables
1. Dem ographic Inform ation ..................................................................................41
2. Comparisons of Control Subjects by State (LA and NH).......................... 42
3. Summary of Hierarchical Regression Analysis for Predictors
of Total Driving Index Without Correction for Miles 
D riv e n ........................................................................................................... 43
4. Correlations of Total Driving Index With Neuropsychological
and Driving Measures Without Correction for Miles 
D riv e n ........................................................................................................... 45
5. Summary of Hierarchical Regression Analysis for Predictors
of Total Driving Index With Correction for Miles Driven........47
6. Comparison of Results of Neuropsychological Test Scores,
Driving Measures, and Total Driving Index by Group................48
7. Correlations of Total Driving Index With Neuropsychological
and Driving Measures With Correction for Miles Driven........49
8. Comparisons of Frequencies of Driving Characteristics by
Kruskall Wallis One Way Analysis of Variance............................50
v
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
A b stra c t
Studies have shown that individuals with Alzheimer's disease have a 
greater number of automobile crashes than normal elderly controls. 
Assessment of driving ability is usually conducted by use of an on-the-road 
examination. These examinations are costly, time intensive, and sometimes 
dangerous. Finding other measures that are predictive of driving ability will 
enable screening of patients to decrease the number of on-road examinations. 
Alzheimer's disease patients and normal elderly control subjects were 
administered neuropsychological measures as well as the Driver Performance 
Test (DPT) and Driver Risk Index (DRI), both videotaped tests of driving 
knowledge and risk assessment. Driving histories based on collateral report
were obtained for each subject, quantifying confusion while driving, moving 
violations, and crashes. These three factors were weighted to provide a Total 
Driving Index (TDI) as an overall indicator of the subjects' driving ability. 
There were no significant differences between the two groups of subjects on 
the TDI, although AD subjects were statistically more likely than controls to be 
rated as unsafe. Predictors of driving ability as measured by the TDI were 
different for the two groups, with Trails A accounting for the most 
incremental variance for AD subjects and Delayed Visual Reproduction 
accounting for the most incremental variance for controls. Results for 
control subjects were significantly better than AD subjects for all 
neuropsychological measures, the DRI, and the DPT Total. These findings 
indicate the need for more sensitive predictors of driving ability which 
includes better assessment of risky driving behaviors.
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In tro d u c tio n
Dementia is one of the most common mental health problems in the 
elderly (Amaducci, Falcini, & Lippi, 1992). Clinically, it is characterized by 
the inevitable progression o f degeneration of neurons within the cerebral 
hemispheres with an accompanying progressive global deterioration of 
intellect and personality (Lezak, 1995).
Alzheimer's disease (AD) was first described in 1907 by Alois 
Alzheimer (Katzman & Jackson, 1991). His patient was a 51 year old woman 
who had a progressive dementia with insidious onset, which included 
language and behavioral involvement. After four years, this woman became 
totally apathetic and incontinent, confined to her bed in a fetal position 
(Franssen, Kluger, Torossian, & Reisberg, 1993). AD was originally 
considered to be a presenile condition, but it has now been accepted as a 
common disorder of old age (Kolb & Wishaw, 1990; La Rue, 1992).
The prevalence of probable AD for people over age 65 is estimated at 
10.3% (Zee, 1993), and, of those who are demented, AD may account for 75% of 
those cases (Edwards, Larson, Hughes, & Kukull, 1991). In the US. cost for 
diagnosis and management of AD is S80 billion annually (Davis &
Haroutunian, 1993). With the increase o f older persons in our population, 
the medical, economic, and emotional ramifications are staggering (Edwards 
et al., 1991). In spite of remarkable progress made in understanding the 
molecular basis of AD, comparatively little progress has been made 
regarding treatment or prevention of this disorder (Pendlebury & Solomon, 
1994).
By definition, AD must involve difficulties with memory as well as 
either aphasia, apraxia, agnosia, or executive functioning disturbance. The
I
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particular cognitive functions that are affected and the severity of these 
dysfunctions can vary greatly, particularly in the mild stages of dementia 
(Butters, Salmon, & Butters, 1994). Additionally, anosognosia has been found 
in the early stages of AD (McGlynn & Schacter, 1989) which impairs the 
individual's judgm ent concerning his or her ability to perform tasks
competently. While this can affect many tasks, such as balancing a 
checkbook or cooking, one that has the greatest potential for personal and
societal danger is driving. Individuals with AD are at risk for unsafe driving 
due to problems with memory, judgment, visuospatial abilities, and 
inattentiveness (Reuben, 1991). Because the cognitive abilities of AD
patients decline in such an unpredictable fashion, it is difficult to determine 
when these individuals should stop operating a motor vehicle. Although 
investigators agree that AD patients must stop driving at some point in their 
disease, there is controversy as to when this should take place. This study 
will investigate the ability of cognitive measures to predict performance of 
AD patients in some basic aspects of driving. Neuropsychological and 
driving measures were used in an attempt to find predictors of driving 
ability, which was quantified by the Total Driving Index (TDI), which 
comprises frequency of getting lost while driving, tickets for moving 
violations, near misses, and crashes as reported by the subjects' collaterals.
It was to be hoped that this information will provide health care providers 
with time effective as well as cost effective measures that will limit the 
number of on-the-road evaluations. The current literature on AD and how
resultant deficits can affect driving ability are reviewed to provide a 
theoretical basis for this proposed study.
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Review of the Literature 
Alzheimer's Disease 
Dementia of the Alzheimer's type is characterized fay multiple
cognitive deficits that begin with a gradual onset and then progressively 
decline, causing significant impairment of daily functioning. The 
particular cognitive functions that are affected and the severity of these 
dysfunctions can vary greatly, particularly in the mild stages of dementia 
(Butters et al., 1994). This insidious dementing process progresses until the 
patient becomes totally oblivious to his or her surroundings and requires
constant care (American Psychiatric Association, 1994). No obvious systemic
features are seen in AD until the late stages when weight loss is apparent 
(Katzman & Jackson, 1991). Although medical technology has allowed 
individuals to live longer, this progress is accompanied by the problem of 
prolonging the period of time patients with AD live a life flawed by
significant functional impairments. AD is the leading cause of dementia and
the fourth leading cause of death in the U.S. (Pendlebury & Solomon, 1994).
P re v a le n c e
For people 65 years of age and older, the prevalence of Alzheimer's 
disease varies from 4.5% to 18.5% (Amaducci et al., 1992). Evans and his 
colleagues (1989) state that prevalence rates are strongly correlated with 
age, ranging from 3% in the 60-74 year old group, 18.7% for people between 
75 and 84 years, and 47.2% for those over 85 years of age. Prevalence rates 
for females are higher in all age groups (Amaducci et al., 1992). Because the 
onset of AD symptoms is so insidious, it is difficult to determine incidence 
rates, although estimates increase exponentially with age and appear to
triple for each additional 10 years after the age of 65. Currently, over four
3
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million individuals in the United States have serious dementia, and this 
dementia will cause an estimated 120,000 deaths per year (Goldman & Cote,
1991).
Description of the Disease 
General Characteristics and Diagnosis
The criteria endorsed by the DSM-IV (American Psychiatric 
Association, 1994) for AD require memory impairment in addition to one of 
the following problems: aphasia, apraxia, agnosia, or disturbance in 
executive functioning. These deficits must cause significant problems with 
social or occupational functioning and must reflect a significant decline
from previous functioning.
AD has been divided into two diagnostic groups, pre-senile. which 
encompasses patients 65 years or below at the time of onset, and senile, 
which includes patients over 65 years at the time of onset (American
Psychiatric Association, 1994). While these are often regarded as discrete
categories, there is controversy as to whether the groups actually have 
different characteristics (Lezak, 1995). Some researchers have found 
greater severity as well as greater attentional problems for the younger 
group (Jacobs et al., 1994), while others have found greater problems with 
language and praxis for the early onset patients (Lawlor, Ryan, Schmeidler, 
Mohs, & Davis, 1994). Additionally, early onset AD has also been postulated to 
result in more rapid cognitive and functional decline than AD with onset 
after age 65 (Jacobs et al., 1994). Other studies have shown no differences 
between the two groups, indicating that the presenile/senile distinction may 
be artificial (Amaducci, Rocca, & Schoenberg, 1986). These conflicting
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
findings serve to emphasize the great variability found in the presentation 
of AD.
Gradual onset of deficits and progressive deterioration are two of the 
defining characteristics that are necessary for diagnosis. Because other 
reversible disorders can show a similar pattern of deficits, these must be 
ruled out before a diagnosis of AD can be made. To eliminate other possible 
etiologies, assessment should include an extensive patient history, medical 
examination, and laboratory testing, comprising at the very least a complete 
blood count (CBC), blood sugar (BS), electrolytes, serum calcium, and thyroid 
stimulating hormone (Patterson & Clarfield, 1994). The history should be 
detailed, and questions should address possible stroke, head injury, 
infections, alcohol or drug abuse, risk factors for AIDS, endocrine 
dysfunction, anemia, and vitamin deficiency (Whitehouse, Lemer, & Hedera, 
1993). When indicators o f other forms of dementia are negative and all 
other criteria are consistent with AD but neuropathological verification has 
not been obtained, a diagnosis of probable AD is given (La Rue, 1992). A 
confirmed diagnosis requires verification from autopsy or biopsy findings. 
P a thophysio log ical Changes
In AD, the cerebral cortex shows dramatic changes, including 
atrophy, neuronal loss, neurofibrillary tangles (NFTs), senile plaques (SPs), 
gliosis, and amyloid angiopathy. Atrophy in AD is shown in the greatest 
amounts in the temporoparietal and anterior frontal areas (Hyman,
Arriagada, Van Hoesen, & Damasio, 1993). This atrophy is usually attributed 
to the loss of neurons in the frontal cortex (DeKosky & Scheff, 1990), corpus 
callosum (Vermersch, Scheltens, Barkhof, Steinling, & Leys, 1993), 
association cortex and certain subcortical nuclei, especially the cholinergic
5
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cells of the nucleus basalis and the serotonergic cells o f the raphe nucleus 
(Blass, 1993). The loss of synapses implies a decrease in connections 
throughout the brain, resulting in a neocortical isolation syndrome 
(Vermersch et al., 1993). This obviously causes a decreased potential for 
neuronal interaction (DeKosky & Scheff, 1990). However, some evidence 
suggests that at least some portion of the atrophy is due to neuronal 
shrinkage rather than actual cell loss (Kemper, 1994). A compensatory 
mechanism has been posited by some investigators (DeKosky & Scheff, 1990) 
that serves to offset the effects of neuronal loss. As the number of neurons 
decrease, the size o f the synapses of the remaining neurons increases, 
which is effective for cell losses up to 35%. Many investigators (Amaducci et 
al., 1992; Blass, 1993; DeKosky & Scheff, 1990; Katzman & Jackson, 1991; Zee, 
1993) have noted the importance of the size of the total synaptic area, 
showing strong correlations between density of synapses and mental status 
sco res .
NFTs and SPs, two of the hallmarks of AD, are also found in normal 
aging; therefore, diagnostic criteria for AD require numbers in excess of 
specific cut-off values (Hyman et al., 1993). Neurofibrillary tangles are 
intracellular accumulations of straight and paired helical filaments, a major 
component of which is the abnormally phosphorylated protein tau which is 
associated with neuronal microtubules (Blass, 1993; Whitehouse et al., 1993).
It has been postulated that impaired transport via altered microtubules may 
be a mechanism of neuronal damage in AD (Blass, 1993). NFTs are 
predominantly located in the pyramidal cells of the neocortex, hippocampus, 
and amygdala as well as the locus coeruleus and raphe nucleus (Hyman et al., 
1993).
6
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Senile plaques are spherical with a dense insoluble amyloid core 
surrounded by glia and distorted cell processes (Whitehouse et al., 1993), and 
these are mainly found in the cerebral cortex and hippocampus as well as 
the corpus striatum, amygdala, and thalamus (Hyman et al., 1993). These
plaques in a diffuse form may be present 10 to 20 years before the
development of the clinical signs and may be a precursor of the dementing
process (Katzman & Jackson, 1991). Amyloid is a fibrillar protein that has a
precursor called APP, or amyloid precursor protein, which is coded by a 
gene on chromosome 21. Although APP is necessary for daily functioning of 
cells, fragments of this protein have been found to be toxic to neuronal cells 
(Katzman & Jackson, 1991). Amyloid is also deposited in the vascular wall by 
microglial cells, serving to thicken the vascular wall, destroy the 
endothelium, and eventually obliterate the vessel (Wisniewski, Wegiel,
Morys, & Bobinski, 1994).
O ther Characteristics
The typical AD patient has memory problems that are temporally 
graded with more recent information being forgotten first (Zee, 1993). The
rate of forgetting increases as the disease progresses. During recall,
intrusions and perseverations are common (Butters, Granholm, Salmon,
Grant, & Wolfe, 1987). Memory diminishes as the disease progresses and by 
the intermediate stage of AD, remote memory is affected (LaRue, 1992).
Language problems begin with word finding problems, 
circumlocutions, and use of vague words (La Rue, 1992; Zee, 1993). Moderate 
AD may be accompanied by increased verbosity but empty content, while in 
the severe phases, language becomes sparse and telegraphic, if the patient 
has not yet become mute (La Rue, 1992).
7
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Fluency performance is related to dementia severity and is useful for 
tracking disease progression, regardless of modality o f presentation 
(Mickanin, Grossman, Onishi, Auriacombe, & Clark, 1994). Word fluency for 
categories is worse for AD patients than letter fluency, which suggests 
breakdown of semantic hierarchies (Chan, Butters, Salmon, & McGuire,
1993).
Problems with spatial orientation (or geographical 
disorientation) may be one of the first signs in AD, and it greatly affects 
daily functioning. This is a form of visual agnosia and may result from 
impairment o f visuospatial memory as well as visuoperceptual dysfunction 
(Zee, 1993). One study (Henderson, Mack, & Williams, 1989) found that 39% of 
their sample had difficulties with spatial orientation, such as getting lost on 
familiar streets, getting lost indoors, and inability to recognize familiar 
p laces .
Constructional/visuospatial ability may be intact in early AD, but it 
may decline sharply (La Rue, 1992). This is shown by difficulties with 
complex visuospatial discriminations, mental rotation (Lezak, 1995), and 
unilateral visuospatial inattention (Freedman & Dexter, 1991). A visuospatial
impairment suggests parietal lobe dysfunction, and indeed, PET scans in 
patients with these problems demonstrate large decreases in glucose 
utilization in right temporal and parietal lobes (Zee, 1993).
Studies have shown that mild (Greenwood, Parasuraman, & Haxby,
1989) and moderate AD patients (Greenwood, Parasuraman, & Haxby, 1991) 
are impaired in the ability to reorient attention, although simple focus of 
attention seems relatively unimpaired. However, Lezak (1995) pointed out 
that even some mildly affected AD patients have difficulties concentrating
8
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on tasks and sustaining attention. Divided attention and shifting of attention 
may be the earliest signs of cortical dysfunction, progressing to difficulties
with arousal and focused attention to stimulus features in the late stages of 
the disease (Parasuraman & Haxby, 1993).
Patients may show a lack of awareness o f their deficits, an 
anosognosia for dementia (Green, Goldstein, Sirockman, & Green, 1993; Zee, 
1993). This loss of insight can involve various degrees of awareness and can 
fluctuate over time and over symptoms. Anosognosia has been found in the 
early stages of AD (McGlynn & Schacter, 1989), and it is said to be caused by 
damage to parietofrontal connections in the right hemisphere (Auchus, 
Goldstein, Green, & Green, 1994; Reed, Jagust, & Coulter, 1993). Neither 
depression nor severity of dementia has been correlated with the presence
of anosognosia (Reed et al., 1993).
Depression is estimated to be present in 20% to 30% of all demented 
patients. Accurate assessment is difficult because demented patients cannot 
accurately remember their symptoms, and caregivers may supply
inaccurate information (Teri & Wagner, 1991). Additionally, in most cases of
geriatric depression, the presenting symptoms are dysthym ia. apathy, or 
anergy, which serves to make diagnosis difficult (Ashford & Zee, 1993).
Behavioral disturbances typically reported in AD include psychotic 
symptoms, apathy, aggressiveness, incontinence, and inappropriate actions 
(Tuokko, 1993). Additionally, "sundowning" (increased confusion and 
agitation in the late afternoon or evening) is a common characteristic in AD 
(Hofman & Swaab, 1994; Satlin, Volicer, Ross. Herz, & Campbell, 1992) and is 
thought to arise from the combined influence of accumulated fatigue and 
the reduced sensory stimulation that occurs as the day's activities wind
9
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down. Psychotic symptoms early in AD predict a more rapid decline (Gilley,
1993) and usually consist of beliefs of belongings being stolen or of an
unfaithful spouse (Raskind, 1993). Estimates of prevalence of psychotic 
symptoms range from 28% to 38% (Zubenko, Rosen, Sweet, Mulsant. & Rifai,
1992).
gtiolQgy Qf AD
The cause of AD is unknown, but, because the symptoms can be so 
heterogeneous, many researchers believe that there are multiple 
underlying causes that combine in various ways in different individuals
(Kay, 1991; La Rue, 1992). Blass (1993) describes this as a convergence 
sy n d ro m e .
Genetic Basis
The genetic theory was first supported by evidence that nearly all
people with Down's syndrome, a known genetic disorder, develop the 
neuropathologic signs of AD, including both amyloid plaques and NFTs, by 
the age of 40 (Blass, 1993; La Rue, 1992; Wurtman, 1985). The neuropathology 
and ensuing dementia is essentially indistinguishable from classic AD 
(Farrer, 1994). Down’s syndrome is caused by mutation of genetic material 
on chromosome 21, and this area is also implicated in some early onset AD 
cases but no late onset cases (Kay, 1991). Other chromosomes known to be 
involved in familial AD (FAD) are 19 and 14 (Bird, Nemens, & Kukull, 1993; 
Brousseau et al., 1994). The familial form of AD appears to be heterogeneous 
with genetic susceptibility associated with AD alterations at a number of 
sites. According to Blass (1993), chromosome 14 is the most common genetic 
abnormality in FAD. Families with this mutation are part of a relatively
10
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small group of AD patients who inherit the disease in an autosomal dominant 
p a t te rn .
However, these genetic findings are tempered by the relatively low 
40% concordance rate among monozygotic twins (Kay, 1991; La Rue, 1992), 
and differences in age of onset that can vary from 6 to 15 years between 
concordant identical twins (La Rue, 1992). This argues for non-genetic 
factors, a position which is further supported by the fact that less than half 
of Down’s syndrome patients have a progressive cognitive decline from 
young adulthood, although they have the neuropathologic characteristics 
(Blass, 1993).
Interest in a genetic factor for AD has increased with the finding that 
there is an over representation of the e 4 allele of the apolipoprotein E gene 
(APOE) in patients with AD when compared to controls (Brousseau et al., 1994; 
Petersen et al., 1995). Brousseau et al. (1994) found the risk of AD was 
approximately 6 times greater for patients having at least one APOE e 4 allele 
than for subjects without the e 4 allele. In a study to assess the predictive 
ability of APOE status, Petersen et al. (1995) followed patients evaluated for 
mild cognitive deficits, which usually involved memory problems. Their 
results indicated that having the e 4 allele of the APOE gene was a strong 
predictor of progressive dementia in those patients having mild cognitive 
impairments. Because the correlation o f APOE status and clinical outcome is 
not perfect, APOE status is useful only as a risk factor and not as a diagnostic 
test.
Blass (1993) stated that genetics plays a variable role in the causation 
of AD. In some families, a genetic abnormality has a dominant role, causing 
the disease in any individual who lives to the age of risk, while in other
11
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family groups, genetics may cause a predisposition, dependent upon 
currently unknown environmental factors. In patients w ithout a family 
history of AD, genetics may not play a role at all (Blass, 1993).
Transmissible Agent Theory
An infectious disease model was proposed because other 
neurodegenerative diseases, such as Creutzfeld-Jacob and scrapie, were 
found to be transmissible (Prusiner & Hsaio, 1994). As in AD, these diseases 
had a late onset o f clinical signs as well as distinctive neuropathological 
structures, although these structures were not the same as those in AD (La 
Rue, 1992; Wurtman, 1985). However, animal studies have not supported the 
possibility of transmission of AD, and there is also no evidence of human 
transmission in personal contact with AD patients or blood transfusions (La 
Rue, 1992).
Environmental Toxin Theory
Epidemiology studies have identified aluminum as an environmental
toxin (Blass, 1993). The aluminum theory is based on the presence of a high
concentration of aluminum within the NFTs and the knowledge that 
aluminum is a known neurotoxin (La Rue, 1992). For example, aluminum 
salts applied directly to the brain cause fibrillary degeneration, although it 
is not the same type of degeneration found in AD (Blass, 1993). However, AD
can develop without high levels of aluminum (Blass, 1993). It may be that
the association of aluminum with the tangles means that once the tangles 
are formed, they have an affinity for aluminum (Wurtman, 1985).
Abnormal Protein Theory
The one neuropathological abnormality required to make the 
diagnosis of AD is a quantity o f amyloid plaques that exceeds a cut-off value,
12
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since amyloid plaques can also occur (in lesser amounts) in the elderly 
without AX) (Blass, 1993). A precursor for amyloid, amyloid protein 
precursor (APP), has become a major focus o f investigation because the S-
amyloid found in the dense neuritic plaques is derived from it (Katzman &
Jackson, 1991). APP is coded by a gene on chromosome 21 and is necessary
for daily functioning of the cells; in fact, an increase in APP during fetal 
brain development is necessary for maintenance of fibroblasts and 
hippocampal cells in culture (Katzman & Jackson, 1991). A systemic origin
for cerebral amyloid is suggested by the presence of this protein in skin,
subcutaneous tissue, and intestine o f AD patients and of some controls 
(Kemper, 1994). A problem with this model is the fact that plaques are
found not only in the parts of the brain affected by AD, but also in the
cerebellum  which is not usually considered to have neurodiagnostic 
changes (Katzman & Jackson, 1991). Additionally, dense plaques occur in the
elderly, even those without cognitive impairment (Blass, 1993). In fact, some
autopsied patients have had sufficient numbers of plaques to meet criteria
for AD but were cognitively intact on repeated testing during life (Katzman
et al., 1988).
A cetylcholine (ACh) Theory
In AD patients, the most characteristic neurotransm itter loss is found 
in the cholinergic system. This is caused by the loss of large cholinergic 
cells in the rostral portion of the reticular activating formation, the septum, 
diagonal band, and the nucleus basalis of Meynert (Blass, 1993). The specific 
measure of ACh in brain tissue is choline acetyltransferase, which is the 
enzyme necessary to synthesize ACh. Its presence can decrease from 60-90% 
in the cerebral cortex and hippocampus (Goldman & Cote, 1991). Since the
13
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mid-1970s, precursors to ACh have been used in an attempt to increase 
cholinergic levels (La Rue, 1992). Choline and lecithin supplements have 
had only limited clinical success, but some improvements have been seen 
with use of cholinesterase inhibitors which decrease the breakdown of ACh 
in the synaptic cleft. Cognex is a drug that has been recently approved for 
patient use; however, the duration of response is unknown (Small, 1992). 
While the losses of ACh are certainly profound, this model does not account 
for lesser decrements in serotonin, norepinephrine, somatostatin, and other 
substances (Blass, 1993).
Inflam m ation Theory
An autoimmune or inflammatory component in AD has been 
considered, citing amyloid as an activating agent that causes an 
inflammatory reaction which contributes to the process of degeneration 
(Blass, 1993; Aisen & Davis, 1994). Aisen and Davis (1994) suggest that 
disruption of the blood-brain barrier (BBB) may be important in starting the 
process of AD. When the integrity of the BBB is disturbed, previously 
protected brain antigens may be exposed to the immune system which may 
initiate inflammatory and immune mechanisms leading to tissue destruction 
in the brain. The inflammatory theory is consistent with evidence that AD is 
less prevalent in those patients who have rheumatoid arthritis, supporting 
the hypothesis that medications used in the treatment of arthritis, such as 
non-steroidal anti-inflammatory drugs (NSAIDS), protect against AD (Broe et 
al.. 1990; Henderson et al., 1992; The Canadian Study of Health & Aging, 1994). 
O ther Theories
Other models have been proposed to explain AD. One that posits that 
the olfactory-limbic connection may provide a route for toxins or infectious
14
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
agents (Goldman & Cot£, 1991). Another model states that mitochondria are 
damaged, which limits the glucose oxidation in the AD brain, producing 
effects of hypoxia (Blass, 1993). The mitochondrion is also a major generator 
of oxidative radicals in the cell, and free radical damage has been shown in 
the AD brain (Blass, 1993).
S u m m ary
All of these investigators have taken a specific aspect of AD and 
produced theories to account for the features related to that aspect.
However, the current theory that AD is a convergence syndrome implies 
that no single event causes AD (Blass, 1993). Similarly, Amaducci et al. (1992) 
suggest that AD is not a single genetic entity, but that it may be caused by 
genetic defects on chromosome 21 and other genetic and non-genetic 
factors. The idea that there are multiple causes provides multiple sites for 
intervention that do not have to be mutually exclusive. Blass (1993) reports 
that subgroups of AD patients may respond differently to different 
treatments. It is only with further research that we will be able to develop 
better interventions and to determine for which groups they will be 
a p p ro p r ia te .
The Controversy Regarding Drivers with Alzheimer's Disease
The approach that investigators have used to study AD - to consider 
one aspect of its presentation - is due to the heterogeneity of its clinical, 
anatomic, and physiological characteristics. Many researchers have noted 
the variety of impairments of patients with AD. For example, although the 
time period from onset of symptoms to death is usually five to ten years, some 
patients have had a precipitous decline that lasts only one to two years, 
while others have had a slow course with plateaus that allows for survival
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greater than twelve years (Friedland et al., 1988). Similarly, AD patients may 
in itially  present with difficulties with visuospatial functioning (Becker, 
Huff, Nebes, Holland, & Boiler, 1988), language impairment (Becker et al., 
1988), or focal neurological abnormalities such as astereognosis and 
pseudoathetosis (Crystal, Horoupian, Katzman, & Jotkowitz, 1981). In a 
longitudinal study, Mayeux, Stern, and Spanton (1985) noted that their 
sample of AD patients clustered into four groups: benign (little to no 
progression of symptoms), myoclonic (severe intellectual decline and 
frequent mutism), extrapyram idal (severe intellectual and functional 
decline and frequent psychotic symptoms), and typical (a gradual 
progression of intellectual and functional decline, but without other 
distinguishing features). The wide variety of clinical presentations 
indicates that no two patients present in exactly the same manner nor are 
patterns of deterioration identical because different abilities will decline at 
different rates for the individual patient as well as for different patients 
(Lezak, 1995). This means that each patient will have different areas of 
intact and impaired functioning and that these will be continually 
changing. This presents difficulties in trying to predict what functions an 
AD patient can perform competently and for how long. This is particularly 
true for driving.
It is acknowledged that at some point virtually all AD patients will 
become incapable of driving safely (Drachman, 1988). However, 
investigators have widely differing views on the method that should be used 
to determine when a patient should cease driving. Because of the danger 
involved and the fact that many individuals with AD did not stop driving 
until they had at least one accident, some investigators (Lucas-Blaustein,
16
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Filipp, Dungan, & Tune, 1988) have recommended that patients who have 
been diagnosed with AD should cease driving immediately upon receiving 
the initial diagnosis. Friedland and his colleagues (1988) made similar 
recommendations because their study indicated that neither severity of 
dementia nor duration of the disease could predict those who could drive 
safely. On the other hand, Drachman (1988) stated that the limitation of 
driving privileges should be based on a demonstration of impaired driving 
skills rather than a medical label such as AD. Additionally, there is an 
increased possibility of misdiagnosis when deficits are mild and patients are 
most likely to still be driving (Hunt, Morris, Edwards, & Wilson, 1993). 
Drachman (1988) further pointed out that decisions regarding a patient's 
abilities to drive are often beyond the scope of an office examination and 
should utilize specialized testing of driving ability, whether simulated or on- 
th e -ro a d .
This controversy is based on findings that have come from various 
studies on AD patients and their driving. Lucas-Blaustein and her colleagues 
(1988) found that 30% of their sample had at least one accident since the 
onset of dementia, and an additional 11% were reported by caregivers to 
have caused an accident. Forty-four percent routinely got lost while 
driving. Similarly, Tuokko, Tallman, Beattie, Cooper, and Weir (1995) found 
that drivers with dementia had 2.5 times more crashes than controls, and 
65% of the patients with possible AD and 21% of the patients diagnosed with 
probable AD had two or more crashes. Other investigators (Friedland et al., 
1988) found that the AD patients were 4.7 times more likely than controls to 
have had at least one crash in the last five years. These studies indicate that
17
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AD patients present a greater driving risk than controls and that having a
crash does not necessarily induce them to stop driving.
While some patients are reported to give up their licenses easily,
others cling to them tenaciously. In fact, in one study, investigators
(Odenheimer et al., 1994) were able to recruit subjects only by promising the 
prospective subjects that the results of the driving tests would not be 
forwarded to the state licensing department. The determination to keep 
their licenses is influenced by many factors. Alternate methods of 
transportation are not often readily available, and this may limit the quality 
of life for these people (O'Neill, 1992). For many people, the ability to drive 
allows independence and socialization (Bloedow & Adler, 1992; Carr et al., 
1991; Retchin, Cox, Fox, & Irwin, 1988), while for some patients, it is essential 
to purchase food, clothing, and other necessities (Carr et al., 1991). If 
driving is limited, these duties may have to be assumed by a caretaker 
(Dubinsky, Williamson, Gray, & Glatt, 1992). The loss of mobility also may 
result in the loss of self-esteem or income (Reubin, Silliman, & Traines,
1988). Cessation of driving can be traumatic, causing a major change in 
lifestyle (Logsdon, Ten, & Larson, 1992), or more importantly, could force an 
unwanted move into an urban area, into a retirement community (Logsdon 
et al., 1992), or into an institution (Carr et al., 1991). Perhaps even more 
important to the patient is the fact that driving represents entry into 
adulthood as well as independence and freedom (Logsdon et al., 1992). These 
quality of life issues must be weighed against the potential risks o f unsafe 
driving to the patient, family, and others (Gilley et al., 1991).
Patients often minimize these risks by saying that they will know 
when to stop driving or that their family will tell them. However, driving
18
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competency cannot be reliably gauged from self-report o f driving skills 
(Hunt et al., 1993). Some persons with dementia continue to drive regardless 
of their deficits and number of crashes experienced (Tuokko et al., 1995). 
Studies that have investigated patient and collateral ratings of recent 
memory, remote memory, attention, and everyday activities show a larger 
discrepancy for judgments of recent memory and everyday activities, a 
smaller one for attention, and minimal discrepancies for judgment about 
remote memory. (Green et al., 1993). Patient self-ratings were significantly 
more positive than familial ratings of patient abilities. It is likely that many 
AD patients cannot recognize that their driving abilities have diminished. 
Unfortunately, even a reliable judgment by a health care professional that 
the patient can operate a vehicle safely can be invalidated quickly by 
disease progression (Gilley et al., 1991).
Factors Involved in Driving 
To evaluate someone's competence as a driver, it is important to know 
the kinds of tasks that must be performed competently to be considered a 
safe driver. Investigators have suggested a plethora of abilities thought to 
be intrinsic to safe driving. The most frequently cited ability was visual 
perceptual functioning (Dubinsky et al., 1992; Koepsell et al., 1994; Logsdon 
et al., 1992; Poser, 1993; Rebok, Keyl, Bylsma, Blaustein, & Tune, 1994). Other 
abilities included judgment (Dubinsky et al., 1992; Fitten et al., 1995; Gilley et 
al., 1991; Koepsell et al., 1994; Poser, 1993), continuous tracking (Dubinsky et 
al., 1992; Fitten et al., 1995), vigilance (Fitten et al., 1995; Gilley et al., 1991; 
Logsdon et al., 1992), route finding (Dubinsky et al., 1992; Gilley et al., 1991; 
Poser, 1993), rapid motor responding (Koepsell et al., 1994; Rebok et al., 1994),
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ability to process multiple environmental stimuli at once (Koepsell et al., 
1994), and memory (Poser, 1993).
While this list is certainly comprehensive, it can not delineate the 
specific cognitive abilities that are necessary for safe driving, because these 
are not known at the current time. However, there is agreement on some 
major domains, which include mental status, attention, visuospatial/visual, 
language, and memory. While other factors such as judgment have been 
proposed, their importance has not been em pirically validated.
Mental status is related to accident rates with three times more 
accidents occurring for those AD patients with poorer mental status as 
opposed to those with better mental status (Owsley, Ball, Sloane, Roenker, & 
Bruni, 1991). The Mini-Mental Status Exam has been used in most driving 
studies (e.g., Odenheimer et al., 1994), and, while it is predictive o f driving 
ability in these studies, it is not sufficient to discriminate those who pass or 
fail the driving examination.
Parasuraman and Nestor (1991) reported that both mild and moderate 
AD patients have marked difficulties with disengaging or reorienting 
attention, although their ability to focus attention may remain intact. This 
attentional shifting is crucial for safe driving (Hunt et al., 1993) in order to 
react to the unexpected events experienced by drivers (Parasuraman & 
Nestor, 1991). Even when most cognitive abilities are still in the normal 
range, difficulties in shifting of attention on tasks can be seen (Rees, Boyer, 
& Phillips. 1995).
Visuospatial confusion may be caused by abnormalities in visual 
scanning behavior (Donnelly & Karlinksy, 1990). Haphazard scanning 
patterns may lead to great difficulty with extracting relevant information
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from a visual search of the patient’s surroundings. In one recent study 
(Fittgen et al., 1995), eye movement measurements were able to distinguish 
between AD patients and patients with vascular dementia, with AD patients 
dem onstrating significantly less scanning movements. Im paired
visuospatial discrimination may be accompanied by a reduction in visual 
fields that the patient is unaware of (O’Neill et al., 1992). Another measure of 
vision, the Useful Field of Vision (UFOV) was failed by all subjects with 
multiple accidents and by those subjects who were involved in 95% of the 
intersection accidents (Owsley et al., 1991). Visual processing abilities are 
essential for driving, particularly a t intersections where most accidents 
occur (Parasuraman & Nestor, 1991).
Language skills have been shown to be related to on-road testing, 
although investigators (Odenheimer et al., 1994) have noted that this may be 
due to the format of their test which relies on verbal instructions. Failure to 
follow a command could be due to lack of comprehension rather than lack of 
ability to perform. Hunt and her colleagues (1993) cited language 
d ifficulties as exacerbating poor road performance because it interfered 
with the patient's ability to understand the comments or advice of 
passengers, lessening the effectiveness of "co-pilots." In a study of stroke 
patients with language impairments, Nouri and Lincoln (1992) found that 
language ability did not significantly contribute to driving safety.
Those components of driving that rely on recent memory, such as 
following a new route, may be difficult for the AD patient (Parasuraman & 
Nestor, 1991). As the disease progresses, individuals may have difficulties 
getting lost on familiar streets and may drive more slowly to compensate for 
uncertainty (Bloedow & Odler, 1992). Parasuraman and Nestor (1991) suggest
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that driving restricted to very familiar routes with minimal traffic may not 
be affected by memory impairment. However, procedural memory remains 
relatively intact for a period of time, and this includes the basic operations 
of driving, such as shifting gears or using the turn signal (Kapust & 
W eintraub, 1992).
Restriction of Driving 
Self-reports of driving habits show a characteristic pattern for AD 
patients. They decrease their miles driven and driving frequency, implying 
an awareness of their driving impairment, but most denied any difficulties 
with driving (Cushman, 1993). Additional strategies used included avoiding 
rush hour traffic, avoiding highway driving, and decreasing their speed, 
but despite these precautions, AD patients still had a higher accident rate 
than controls (Dubinsky et al., 1992). This may be explained by the fact that 
these strategies are not sufficient to compensate for the AD patient's deficits. 
Parasuraman and Nestor (1991) suggest that basic deficits such as inability to
shift attention cannot be ameliorated by driving more slowly or by paying 
closer attention to the road.
The deficits that are incurred by AD patients as their disease 
progresses have been studied in relation to driving, and a summary of these 
investigations follows.
Empirical Studies of Alzheimer's Disease and Driving 
van Zomeren and Brouwer (1994) explained that there are two 
methods of investigating driving skills. In the first, driving ability is 
evaluated in a natural setting in which the subject drives in a variety of
traffic situations that are meant to be representative o f everyday driving.
The second method uses another criterion measure such as number of
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crashes or one or more critical driving subtasks or driving-related abilities. 
These methods will be discussed.
Hunt and colleagues (1993) evaluated 13 healthy controls and 12 
subjects with very mild AD and 13 subjects with mild AD on a road test that 
was scored independently by two evaluators. Subjects and their collaterals
were interviewed separately to obtain their opinion of the subject's driving 
ability. All control subjects and very mild AD subjects passed the on-road 
test; however, five (40%) of the mild AD subjects were impaired to such a 
degree that they failed the road test. Of those that failed, inappropriate 
driving behaviors included coasting to a stop in traffic, stopping abruptly 
without a cause, and simultaneously pressing the brake and accelerator 
while driving. Neither subject self-assessment nor collateral assessment of 
the subject's driving consistently predicted ability to drive safely. Driving 
scores were most highly correlated with attentional abilities. These 
investigators found that healthy elderly individuals and at least some of the 
very mild and mild AD subjects were considered to be safe drivers.
A study by Odenheimer and her colleagues (1994) involved an on-the- 
road driving test with closed course and in-traffic components which was 
given to 24 elderly subjects and three AD patients as well as three patients 
with vascular dementia. Tests that significantly correlated with driving 
scores included the Mini-Mental State Exam (MMSE), visual and verbal 
memory subtests of the Wechsler Memory Scale-Revised (WMS-R), Trails A, 
traffic sign recognition, and a computerized complex reaction time test. 
Although there was a strong correlation between the MMSE and the on-the- 
road test scores, the four drivers who failed the driving test had MMSE scores 
of 4, 16, 21, and 24, while the lowest MMSE score of a subject that passed was
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14. This overlap indicates that MMSE scores are not sufficient to predict 
driv ing  perform ance.
The most recent o f these studies (Fritten et al., 1995) provided on-the- 
road data from an assessment of the abilities of fifteen mild AD patients, 
twelve multi-infarct dem entia (MID) patients, fifteen age-matched controls 
with diabetes, and sixteen young subjects. Patients with a history of mild AD 
or MID performed significantly worse on the road test compared to control 
subjects. The three best predictors of the driving score were the MMSE, 
visual tracking, and a memory test. However, the MMSE score at the upper 
end of the range did not correlate well with the driving score, which is a 
limitation for the MMSE as a screening device.
The information provided by these three studies suggests that some AD 
patients are capable of driving in a safe manner, although many exhibit 
dangerous behaviors during the road test. Additionally, while the MMSE was 
predictive of driving scores, it was not sufficient by itself to discriminate 
those patients who passed the road test and those who didn't. Although these 
studies are difficult to compare due to differing test batteries, two of the 
three studies showed attention to be a significant factor in predicting 
driving scores.
Another method of studying driving behavior involves using a 
criterion measure for driving other than an on-the-road test. Two of the
studies reviewed have used some form of driving status as their grouping 
variable. Retchin and colleagues (1988) used categories of frequent drivers, 
occasional drivers, and nondrivers, and they found that these categories 
were predicted by dynamic visual acuity, nondominant grip strength, and 
peripheral vision, but not cognitive impairment. Alternatively, Logsdon et
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al. (1992) used groups of individuals who, by collateral report, were driving 
without difficulty, driving with difficulty, and those who had stopped 
driving due to cognitive deficits. Findings showed that mean MMSE, DRS, and 
visuospatial task scores were significantly different between drivers and 
nondrivers, but no significant difference was found between those who had 
a change in driving ability and those who had problems but were still 
driving independently. These studies demonstrate that there is no clear 
relationship between severity of dementia and driving status, but due to the 
grouping variables selected, no other conclusions can be drawn.
An alternate method of considering driving abilities in AD is to use 
questionnaire data from collaterals that involves number o f crashes before 
and after onset of dementia symptoms. This strategy has been used by 
investigators who studied patterns of crashes in AD (Drachman & Swearer,
1993; Dubinsky et al., 1992; Gilley et al., 1991) as well as those who studied
neuropsychological differences between AD drivers who were still driving 
and those who were not (Lucas-Blaustein et al., 1988). In the latter study, 
neuropsychological scores were compared between those AD patients who 
were still driving and those who had stopped driving.
A slightly different format was used by Rebok and his colleagues
(1994) who used the Driver Performance Test (DPT; Weaver, 1985) and the 
Driving Advisement System (DAS; Gianutsos, 1988) as tapping driving-related 
abilities and compared these scores with various neuropsychological tests. 
They found that the visual and verbal memory scores and category fluency 
scores correlated highly with their driving measures and therefore 
suggested that these paper and pencil measures could be used to predict
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driving ability, with the caveat that they lack the face validity of the 
driving measures.
Consideration o f Previously Used Methodologies 
In efforts to determine the effects of the deficits of AD patients in 
driving, investigators have been using on-road tests and survey methods. 
Currently most evaluations have an on-road test as the final decision factor. 
However, these tests have limiting factors for use with AD patients. Some 
investigators (Fritten et al., 1995) have suggested that these patients must be 
re-tested frequently because the progression of their disease may render 
them incapable of safe driving in a relatively short period of time. However, 
these on-the-road evaluations are costly and time consuming. Kapust and 
Weintraub (1992) estimated the cost per on-road evaluation to be SI200 per 
patient. Several investigators (Hunt et al., 1993; Odenheimer et al., 1994) who 
used on-road testing have a course that takes approximately an hour to 
complete in order to provide a wide variety of driving situations.
Additionally, other screening measures must additionally be performed to 
ensure some modicum of safety before allowing road tests (Odenheimer et al., 
1994). Although attempts have been made to standardize these courses 
(Odenheimer et al., 1994), changing traffic conditions cannot be duplicated, 
and closed courses do not allow for testing of the patient's interaction with 
other vehicles. Similarly, subjects are often closely directed and asked only 
to follow single commands, minimizing the effect of other factors such as 
getting lost (Odenheimer et al., 1994) and the ability to follow sequential 
directions (Drachman & Swearer, 1993). As Jones, Giddens, and Croft (1983) 
stated, an on-the-road test "has the disadvantages of low objectivity, low 
reliability, and often low safety levels." On-road driving examinations may
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not be challenging enough to indicate the ability of AD patients when faced 
with more complex and stressful traffic situations that surpass their 
cognitive and decisional capabilities (Hunt et al., 1993). That information is 
supplied by moving violation and crash data.
An alternative to on-the-road tests are the use of simulators.
However, these involve the purchase of expensive equipment (Rebok et al., 
1994) and do not typically correlate well with driving performance 
(Dubinsky et al., 1992; Owsley et al., 1991).
Use of crash data is supported by the report of Owsley and her 
colleagues (1991) who argue that the use of crash data is preferable to on­
road testing if the goal is to predict and eventually reduce crashes. 
Additionally, if an on-road test was to be used to determine who was at risk 
for accidents, the test would have to be validated against crash frequency. 
Tuokko and her colleagues (1995) reported that on-road testing and survey
data show consistent findings despite variations in methods and sampling 
procedures. Other investigators (Gilley et al., 1991) point out that crash rates 
alone may underestimate the patients' difficulties. Their sample had 
relatively frequent tickets and rule infractions as noted by collaterals, even 
in those patients who had no crashes. Therefore, summation of crash data,
moving violations, and rule infractions should provide comprehensive 
in fo rm a tio n .
Rationale for Studv 
It is evident from a review of the literature on driving and AD, that AD 
patients have a greater risk for automobile crashes than controls (Dubinsky 
et al., 1992; Friedland et al., 1988). Investigators have shown that having
crashes does not necessarily change an AD patient's driving status, often
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leaving the caregiver or health professional the unpleasant task of 
persuading the patient to stop driving (Friedland et al., 1988; Gilley et al., 
1991; Lucas-Blaustein et al., 1988).
Deciding when a patient should stop driving is not an easy task. Those 
affected with AD may plateau in their symptom progression or may present 
with a pattern of deficits that allows for safe driving. Currently 
performance-based (on-road) tests are used to determine safe driving in 
individuals, but these tests are expensive and time intensive. It should also 
be noted that some investigators recommend these on-road tests be given 
repeatedly to check for possible disease progression that would affect 
driving safety. Brief screening measures that are clearly predictive o f 
driving abilities need to be developed (Hunt et al., 1993; Robbins &
W eintraub, 1992).
While many abilities have been suggested as being important to 
driving safety, research has not been done to determine the measures that 
would best predict safe driving. Therefore, measures indicative of driving 
ability should be used to ascertain the best predictors for driving ability. 
Determining predictors of safe driving ability in AD would allow for 
screening that could eliminate on-road testing for those patients that would 
be most dangerous on the road.
Measures that will be considered as predictors include the Mini- 
Mental State Examination (MMSE), Trails A and B, Boston Naming Test (BNT), 
Logical Memory (LM) and Visual Reproduction (VR) from the Wechsler 
Memory Scale-Revised, and Category Fluency. These tests have been found 
to correlate with driving ability in previous investigations. The Driver 
Performance Test (DPT) and Driver Risk Index (DRI) are videotaped tests of
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driving ability. The DPT assesses knowledge of driving skills, while the DRI 
evaluates the patient’s ability to estimate the risks inherent in driving.
This study is designed to assess the utility o f various cognitive tests 
and measures of driving-related abilities as predictors for driving ability. 
Similar to many studies regarding driving in dementia, collateral report was 
used to provide information regarding the demented patients’ driving record 
(Drachman & Swearer, 1993; Dubinsky et al., 1992; Gilley et al., 1991; Logsdon 
et al., 1992; Lucas-Blaustein et al., 1988; Wagner, Bachman, Cushman, Waid, & 
Hummer, 1994). Collateral report has been validated for use in studies that 
gather data that is subjective or cannot be obtained by other means (Logsdon 
& Teri, 1995; Rocca et al., 1986). Logsdon and Teri (1995) investigated AD 
patients’ levels of depression by comparing three collateral questionnaires, 
a caregiver structured interview, and a patient structured interview. 
Correlations of the report measures were significant at the p<.0001 level, 
supporting the concept that caregivers can act as accurate reporters of 
depression in AD. This evidence for the accuracy of collateral information is 
important in the current study because of the limitations of the DMV 
records. Department of Motor Vehicles (DMV) records reflect only police- 
reported accidents. In a study by O’Jile (1994) that compared the driving 
records of head injured subjects and non-head injured controls, the self- 
reported records of the head injured subjects were consistent with the DMV 
records, but controls reported more crashes than the state records revealed.
In a study that dealt with elderly patients, Tuokko and her colleagues (1995) 
in Vancouver, British Columbia used a combination o f Motor Vehicle Branch 
(MVB) data and insurance company data (since there is only one insurance 
carrier in that province). Their paradigm was limited by the amount of time
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records are kept in the MVB. In the US, many states limit their records to 
three years of data. Tuokko et al. (1995) found that elderly subjects may have
more frequent minor crashes that may go unreported to the police. Finally,
Dubinsky et al. (1991) pointed out that subjects would be less likely to
participate in research if they were informed that the accident data would
be obtained from the DMV. Therefore, because DMV data is limited by the 
type of accidents reported and the length of record-keeping, collateral data 
was obtained for this study. Data collected included information concerning
the last six years of driving for controls or from date of onset of dementia 
symptoms for AD patients. Using collateral data also permits the collection of 
more subjective data such as quality of driving. This period of six years is
based on investigations (e.g., Logsdon, Teri. and Larson, 1992) in which all
AD subjects had discontinued driving by six years after onset of dementia 
symptoms. Therefore, data for this period of time was collected by collateral 
report to derive the TDI for each subject.
Research Questions and Hypotheses
This study compared the driving performance and predictors of that 
performance for subjects with AD and elderly controls. Neuropsychological 
tests were correlated with driving performance as measured by the TDI, 
comprising measures of patient confusion while driving, moving violations, 
and crashes. The literature in this area gives indications o f results that were 
expected to be replicated in this study. These included: 1) more automobile 
crashes would be found for AD subjects than for normal elderly controls, 2) 
subjects with AD and elderly controls would consider themselves to be 
equally competent to perform on the driving-related tests, although the AD 
participants were expected to score significantly lower than controls, and 3)
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the AD subjects would score significantly lower than controls on the DPT. 
However, there are issues that previous studies had not addressed.
Hypothesis 1. The first hypothesis was that predictors of driving
ability as measured by the Total Driving Index will be different for the two 
groups. Specifically, for AD subjects, the MMSE, DPT, DRI, and Trails A and B 
would account for significant incremental variance in the criterion 
variable. For controls, only the DPT and DRI would account for significant 
increm ental variance.
Hypothesis 2. Driving ability as measured by Total Driving Index would
correlate significantly with all measures (DRI, DPT, MMSE, Trails A and B, 
BNT, LM, VR, and Category Fluency) for AD subjects. Significant correlations 
for controls would be found for DRI and DPT.
Hypothesis 3. The error scores on the DRI would be significantly
higher for AD participants than for the normal controls.
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M ethod
Subjects
A total of fifty individuals served as subjects, 25 of which were 
diagnosed with AD, meeting DSM-IV criteria. An additional 25 normal 
controls of equivalent age and education also participated, with 18 of these 
subjects recruited in the state o f Louisiana and 7 recruited in the state of 
New Hampshire. AD subjects and controls were recruited from the 
Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire; AD 
subjects were also recruited from  a neurologic clinic in Fort Lauderdale, 
Florida; and control subjects were also recruited in Baton Rouge, Louisiana 
under the auspices of Louisiana State University. AD subjects were examined 
by a neurologist (FL) or a team of a neurologist and a geropsychiatrist (NH) 
who provisionally diagnosed these subjects with senile dem entia of the 
Alzheimer's type. All AD subjects received physical and neurologic exams as 
well as blood tests (for thyroid screen, CBC, SMAC, etc.) and neuroimaging to 
assess for other possible causes of dementia. Control subjects were recruited 
from a retirement apartment complex (LA) or from a hospital Volunteer 
Services Department (NH). Individuals were screened for significant 
alcohol or drug use as well as for physical illness that could potentially 
compromise cognitive functioning. Controls were screened by MMSE, and 
scores for controls were above those scores considered to be indicative of 
possible dementia (above 23/30). The controls were in good health, lived 
independently in the community, and had no history of progressive memory 
or cognitive impairment. All subjects had a collateral who was familiar 
with the subject's driving. Additionally, all subjects have driven for at least 
10 years, and AD participants had driven for at least one year after the onset
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of dementia symptoms. All control subjects were currently driving, as were 
all but two of the AD subjects. These two subjects had stopped driving 
recently (one stopped one month prior to testing and the other stopped 
driving two months before testing). AD subjects and controls were 
matched by age and sex. The date o f onset of dementia symptoms for the AD 
participants was used as the corresponding start date for the control subjects 
for comparison of driving events.
M easu res
Dem ographic/Driving H istory Q uestionnaire
A questionnaire regarding demographics and driving habits was 
administered to all subjects and their collaterals (see Appendix A). 
Collateral-reported driving data was obtained for the last six years for all
control subjects, while for AD subjects, data was collected for that period of
time since onset of symptoms until the date of cessation of driving or the
date of testing for this study. This allowed for between groups comparison of
driving since dementia symptom onset (Drachman & Swearer, 1993). 
Additionally, both controls and AD subjects were asked to estimate how well 
they performed on the DPT and DRI. This provided an opportunity for AD 
subjects to demonstrate the accuracy with which they could assess their 
ability regarding driving related measures. This has a direct bearing on 
their ability to accurately assess their driving skills.
Mini-Mental State Exam
The Mini-Mental State Exam (MMSE; Folstein, Folstein, & McHugh,
1975) is probably the most widely used dementia screening measure. It 
assesses a restricted number of cognitive domains quickly (Lezak, 1995). 
Scores of 23 and lower are considered to be abnormal when screening for
33
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
dementia. Basic functions assessed include attention, memory, verbal 
functions, and construction. High twenty-four hour test-retest reliability 
was found in the original study, .89 for the same examiner and .83 for 
different examiners (Folstein et al., 1975). As stated before, this measure has 
been found to be correlated with driving scores in several studies, and it is 
expected to account for significant incremental variance.
Trail Making Test
The Trail Making Test is widely used as a measure of visual conceptual 
and visuomotor tracking (Lezak, 1995). Part A involves tracking sequential 
numbers while Part B requires alternation of numbers and letters. Errors 
are not counted but are pointed out by the examiner and corrected by the 
patient, and the time taken for correction is included in the total time of the 
test. Part A has been found to have the ability to document the progress of 
even mild dementia (Botwinick, Storandt, Berg, & Boland, 1988), and has been 
predictive of driving scores in several studies (Hunt et al., 1993; Odenheimer 
et al., 1994). Reliability coefficients of Part A were found to be .69 to .94, 
while Part B showed .66 to .86 for various neurological groups (Snow,
Tierney, Zarzitto, Fisher, & Reid, 1988). Trails B is the more sensitive of the 
two tests (Spreen & Strauss, 1991), and a patient's difficulties with this test 
could indicate problems such as inability to shift attention during on 
ongoing task (Pontius & Yudowitz, 1980) or the inability to deal with more 
than one stimulus at a time (Eson, Jen, & Bourke, 1978). Use of Trails B as a 
possible predictor of safe driving is supported by the suggestion of 
Parasuraman and Nestor (1991) that this measure assesses the ability to shift 
attention between visual locations which is impaired in AD. Trails A and B
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are expected to account for significant incremental variance in the Total 
Driving Index, the criterion variable.
Boston Naming Test
The Boston Naming Test (Kaplan, Goodglass, & Weintraub, 1978) 
consists of 60 line drawings which are presented one at a  time for the 
patient to name. If the patient does not produce the word spontaneously, two 
prompts (semantic and phonemic) may be given (Spreen & Strauss, 1991).
An original form of the test was divided into two equivalent forms, and 
between-forms correlations were found to be .81 for normal controls and .97 
for AD subjects (Huff, Collins, Corkin, & Rosen, 1986). Williams, Mack, and 
Henderson (1989) used an experimental version with the current BNT
divided into two forms using the odd and even numbered items. These three
forms discriminate well between AD, other types of dementia, and elderly 
controls. While this measure has been significantly correlated with driving 
scores (Hunt et al., 1993), it is not expected to account for significant 
incremental variance in the hierarchical regression. This is due to the
relatively small role of language in driving.
W echsler Memory Scale-Revised: Logical Memory
Logical Memory (LM) from the Wechsler Memory Scale-Revised 
(Wechsler, 1987) assesses the ability to recall ideas from two stories that are 
read aloud to the patient. Immediate and delayed recall are assessed.
W echsler (1987) reported that the interscorer reliability coefficient was .99. 
The LM has been found to be useful for identifying and tracking dementia 
(Storandt, Botwinick, & Danziger, 1986). Although verbal memory is a
significant problem in AD, due to the overleamed nature o f the driving 
process and the restrictions that individuals with AD self-impose, limiting
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the role of verbal memory, it is not expected to account for significant 
increm ental variance in the final regression equation.
W echsler Memory Scale-Revised: Visual Reproduction
Visual Reproduction (VR; Wechsler, 1987) consists of four items (three
with a single figure and one with two figures), and these are shown to the
subject for 10 seconds and then withdrawn. Subjects are asked to draw them 
immediately and again after a thirty minute delay. A reliability coefficient 
for scoring of .97 was reported (Wechsler, 1987). VR is very sensitive to the 
effects of dementia (Mitrushina, Satz, Gayer, & McConnell, 1988). The 
restrictions that AD drivers impose upon themselves and the ability to have
someone else in the automobile help "navigate" leads to the prediction that
VR will not be a predictor that accounts for significant incremental
variance in the criterion variable, and it is not expected to contribute
sig n ifican t increm ental variance.
Category Fluency
Category Fluency is a 60 second naming test in which subjects are 
asked to produce exemplars of a category. Monsch and her colleagues (1992) 
found that this test provided greater sensitivity (100%) and specificity
(92.5%) than letter fluency with a sensitivity of 88.8% and a specificity of 
84.9% for discriminating AD subjects from elderly controls. Although this 
measure has significantly correlated with measures o f driving skills (Rebok 
et al., 1994), it is not expected to account for significant incremental
variance in the criterion variable.
Driver Performance Test
The Driver Performance Test (DPT; Weaver, 1985) is a 36 minute 
videotaped test that consists of driving situations with questions regarding
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these situations to be answered in a multiple choice format. Each situation 
exemplifies one of five abilities: 1) s e a rc h  for factors that might present 
danger, 2) id e n tify in g  those situations, 3) p re d ic t in g  the effect o f the 
dangerous factors, 4) d ec id e  the appropriate action, and 5) ex ecu te  the 
proper response. A subscore for each of these abilities as well as a Total 
Score is derived from each subject's performance. Standardization data was 
based on 8000 experienced drivers with a mean annual driving exposure of 
15,000 miles. A Total Score below 130 (out of a possible 200 points) is 
associated with probable collision frequency. Because of the relationship of 
the Driver Performance Test Total score with crash frequency, it is expected 
that the DPT will account for significant incremental variance in the TDI.
Driver Risk Index
The Driver Risk Index (DRI; Weaver, 1985) is a measurement of a 
driver's risk taking potential in a driver. Fifty risk-related scenes are
shown, and a statement regarding the situation is made by the narrator,
which the subjects indicate is true or false. Scores were based on a
standardization sample of 600 drivers. It is expected that this measure will
account for significant incremental variance in the TDI.
P ro ced u re
AD participants and control subjects were administered a
questionnaire with items consisting of demographic and driving history 
queries. For all subjects, experimental and controls, collaterals were asked to 
answer these questions for the patient. The information provided by the 
collaterals were used as the statistical basis for the Total Driving Index. A 
weighting system was used to derive the Total Driving Index for the 
criterion variable. The first factor in the weighting system was a Patient
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Perplexity Index that is similar to one that was used by Wagner et al. (1994). 
These investigators used an index composite score to reflect the family’s 
perception of unsafe driving. Their index of general safety included five 
measures of frequency of unsafe behavior: episodes o f getting lost, episodes 
of near misses, problems with attention, problems with directions, and 
necessity for the driver to have someone with him or her to drive safely. 
These resulted in a "frequency of unsafe driving behavior." In the current 
study, the Patient Perplexity Factor is made more objective by limiting this 
factor to the number o f incidents in the last year of driving of getting lost 
while driving and episodes of near misses as reported by the collateral.
These events were added and weighted times a unit of one. Collateral report 
of the number of moving violations since onset of dementia symptoms for AD 
participants (or an analogous for controls) were weighted times a unit of 
two, and collateral report of the number of crashes since onset o f  dementia
symptoms for AD subjects (or an analogous time for controls) were weighted 
times a unit of three. Summation of these factors provide a Total Driving 
Index that allows for the consideration of the incremental seriousness of 
these events within a total score. The Total Driving Index was computed 
based on subjective appraisal by the collateral of the subject's driving 
behavior for a year as well as collateral report for the more objective
measures (tickets and crashes) which were assessed for the length of time
since onset of dementia symptoms for the AD subjects and a comparable time 
period for the controls. The finish date for these computations was either 
when the patient stopped driving or the date when the examination for this
study occurred.
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All subjects were administered the MMSE, Trails A, Boston Naming 
Test, Logical Memory I and II, Visual Reproduction I and H, and Category 
Fluency. All of these tests have been shown to correlate significantly with 
driving measures in the literature. Additionally, subjects were administered 
Trails B. Although this has not been correlated with driving measures in the 
past, its use is justified by the difficulties individuals with AD have shown in 
switching attention between visual locations (Grady et al., 1988; Greenwood 
et al., 1989). The order of neuropsychological test and driving measures 
were alternated to control for possible order effects. Two AD subjects 
fatigued quickly, and the testing was completed over two consecutive days 
for these subjects.
The subjects were also administered the DPT and DRI. While the DPT 
has been used in previous investigations with AD subjects (Rebok et al.,
1994), the DRI has not. However, AD participants have been noted to have 
more crashes at intersections (Kaszniak, Kyis, & Albert, 1991; Owsley et al., 
1991), while changing lanes (Kaszniak et al., 1991), and at traffic signals 
(Friedland et al., 1988). This suggests that, when presented with a complex
situation, persons with AD are less able to adequately determine the risk
involved in their actions. Therefore, the DRI scores should provide a
reflection of the subjects' ability to make a judgment regarding risk. In
addition, these two tests could be a valuable part of a screening battery for 
driving because they provide face validity for clinical decisions regarding 
driving abilities. This is important because other effective measures may 
not be seen by the patient as having any relationship to the driving process.
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R esults
Preliminary univariate tests were conducted to obtain a description of 
the sample characteristics. A summary of demographic data is shown in 
Table I.
Comparisons of the two groups' demographic data were performed to 
determine if there are significant differences between the experimental 
groups. AD subjects and control subjects were matched by sex, with each 
experimental group consisting of eleven males and fourteen females. 
Experimental groups were also equivalent in age (t(48)=0.82, n.s.) and 
education (t(48)=l.87, n.s.).
Because control subjects were recruited from two separate locations 
(Louisiana and New Hampshire), comparisons were made to ensure that 
these control subjects were not significantly different for any of the 
parameters used. No significant differences were found between age, 
education, years driven, and all neuropsychological and driving measure 
scores for the two groups o f control subjects. These results are summarized 
in Table 2.
Tests of Hypotheses
Hypothesis 1 which stated that predictors of driving ability would be 
different for the two groups was tested by stepwise regression. It was 
expected that the MMSE, DPT, DRI, and Trails A and B would be predictive of 
driving ability as measured by the Total Driving Index for the AD subjects, 
while the DRI and DPT were postulated to be predictive for the control group. 
For each group, the Total Driving Index was regressed upon the 
neuropsychological and driving measures (MMSE, LM1, LM2, VR1, VR2,
Trails A, Trails B, BNT, Category Fluency, DPT, and DRI) using forward
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stepwise regression. (See Table 3 for results.) Among the AD subjects. Trails 
A was the only significant predictor of the Total Driving Index, although the 
DRI approached significance (jl=0.06). Changes in R- were obtained for each 
of these independent variables: Trails A accounted for .224 of the 
increm ental variance (jl=0.02), and the DRI accounted for .126 of the 
increm ental variance (j>=0.06). Among the control subjects only Visual 
Reproduction II was significantly related to TDI (p=0.01), accounting for .293 
of the incremental variance. Therefore, Hypothesis I was only partially 
su p p o rted .
Table 1
D em ographic Inform ation
AD Subjects Control Subjects
N 25(11 Males, 14 Females) 25 (11 Males, 14 Females)
A ge 77.48 (6.91) 74.40 (4.50)
E ducation 13.72 (3.66) 13.04 (1-95)
Mean Months 
Stopped Driving 0.12 (0.44) 0.00 (0.00)
Years Driven 56.76 (10.80) 47.52 (12.05)
Miles Driven/W eek 53.40 (53.44) 115.00 (101.28)
Hypothesis 2 stated that driving ability as measured by the Total
Driving Index will correlate significantly with all measures (DRI, DPT, 
MMSE, Trails A, Trails B, BNT, LM, VR, and category fluency) for all AD 
subjects. It was likewise hypothesized that the DRI and DPT would be 
significantly correlated with the Total Driving Index for control subjects. 
Correlations were performed between Total Driving Index and all 
neuropsychological and driving measures for both groups. For the AD
41
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Table 2
Comparisons of Control Subjects bv State (LA and NTFO 
____________________ LA (18 subjects)__________ NH (1 subjects)
P a ra m e te r M ean M ean §D t
e.
A ge 74.94 (4.87) 73.00 (3.27) 1.15 n.s.
E ducation 12.44 ( I . 10) 14.57 (2.28) 6.7 n .s.
Yrs Driven 46.22 (12.56) 50.86 (10.75) -0.92 n .s.
MMSE 28.28 (1-64) 28.29 (1-98) -0.01 n .s.
LM1 19.61 (5.64) 24.43 (8.12) -1.44 n .s.
LM2 13.56 (6.34) 19.71 (8.98) -1.66 n .s.
VR1 27.56 (6.09) 33.43 (6.40) -2.09 n.s.
VR2 19.78 (8.26) 27.86 (9.32) -2.01 n.s.
Trails A 51.72 (20.88) 41.71 (10.19) 1.60 n.s.
Trails B 108.56 (39.51) 82.00 (27.05) 1.63 n.s.
BNT 55.00 (2.17) 56.86 (3.72) -1.24 n.s.
C ategory
Fluency
14.72 (3.98) 20.71 (6.80) -2.19 n.s.
DPT 115.00 (17.10) 119.14 (11.08) -0.71 n.s.
DRI 16.22 (5.02) 14.71 (4.03) 0.78 n.s.
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Table 3
Summary of Hierarchical Regression Analysis for Predictors of Total Driving 
Index Without Correction for Miles Driven
V a ria b le  B value Standard Error S value s .
For AD Subjects:
M M SE0.15 0.14 0.30 0.32
LM1 0.24 0.13 0.68 0.09
LM2 -0.20 0.13 -0.49 0.15
VR1 0.05 0.07 0.20 0.51
VR2 0.16 0.16 0.29 0.33
Trails A 0.03 0.10 0.49 0 .02*
Trails B 0.00 0.00 0.05 0.84
BNT -0 .0 1 0.06 -0.06 0.88
Category N am ing-0.13 0.12 -0.32 0.30
DPT -0.06 0.04 -0.35 0.14
DRI 0.20 0.10 0.37 0.06
For Control Subjects:
M M SE-0.10 0.20 -0.14 0.61
LM1 -0.12 0.11 -0.61 0.29
LM2 0.10 0.09 0.61 0.27
VR1 0.04 0.09 0.20 0.69
VR2 -0.07 0.02 -0.54 0.01**
Trails A -0 .0 1 0.02 -0.17 0.58
Trails B 0 .0 1 0.01 0.16 0.68
BNT 0.06 0.13 0.13 0.66
Category N am ing-0.02 0.08 -0.14 0.69
DPT 0.02 0.03 0.25 0.48
DRI 0.02 0.07 0.06 0.83
Significant at p<0.05 
Significant at p^).Ol
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group, there was a significant correlation between the Total Driving Index 
and Trails A (r=0.39, p=0.05) For control subjects. Total Driving Index 
correlated significantly with Visual Reproduction I (r=-0.49, p.=0.0l) and 
Visual Reproduction II (r=-0.54, p=O.Ol). (See Table 4.) Therefore, this 
hypothesis was partially supported for the predictions made for the groups.
To test Hypothesis 3, a t-test was performed to compare DRI scores for 
both groups. It was postulated that AD subjects would score significantly 
higher (more errors) on the DRI than control subjects. This hypothesis was 
supported by the results of a two-tailed t-test (t(48)=-2.34, jl<0.02) and lends 
support for the prediction that AD participants are less able to correctly 
determine how risky a situation might be.
Additional Analyses 
Miles driven per week were analyzed by a t-test between the two 
groups, with the controls driving more than twice as far (M=115 miles) as AD 
subjects (M=53.4 miles) (t(45)=2.69, jl=0.01). Because there was such a large 
discrepancy between the groups for miles driven per week, a Corrected Total 
Driving Index was devised which controlled for this discrepancy. New
regressions were performed. Among the AD subjects, both Trails A and the 
DRI were significant predictors of the Corrected Total Driving Index. (See 
Table 5). Incremental changes in R - for these variables were .198 for Trails 
A (g=0.01) and .120 for the DRI (p=0.04). For control subjects, only Visual 
Reproduction I was significantly related to Corrected TDI (jl=0.02), 
accounting for .218 of the incremental variance.
Comparisons were made between scores on neuropsychological 
measures of AD subjects and control subjects, using t-tests. On all measures,
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controls scored significantly better than AD subjects. (See Table 6.) Scores 
for the DPT Total Score and its subtest scores were also compared by group 
using t-tests, which showed significant differences between the groups for 
the DPT Total score as well as for two subtests, search and execute. (See 
Table 6.)
A t-test was also used to compare years driven by the AD and control 
subjects, with the AD subjects having driven significantly longer than the 
controls (t(58)=2.86, g_=0.01).
Table 4
Correlations of Total Driving Index With Neuropsychological and Driving 
Measures Without Correction for Miles Driven
M easu res
AD Subjects 
C o rre la tio n P
Control Subjects 
C orre la tio n  d
MMSE 0.02 .94 -0.39 .06
LM1 0.09 .68 -0.28 .17
LM2 -0.06 .78 -0.17 .41
VR1 -0.08 .69 -0.49 .01*
VR2 0.14 .51 -0.54 .01*
Trails A 0.39 .05* 0.18 .38
Trails B 0.01 .99 0.32 .12
BNT -0.07 .75 0.05 .80
Category Fluency -0.10 .60 0.29 .08
DPT -0.07 .73 -0.29 .16
DRI 0.24 .25 0.29 .16
* Significant at p.<0.05
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A BCruskall-Wallis One-Way Analysis of Variance was used to compare 
driving styles and other driving factors. (See Table 7.) Results indicate that 
all subjects drove alone, and there were no significant differences between 
the groups for use of medication or restriction of driving (e.g., only during 
the day or only in the neighborhood). None of the collaterals rated a 
control's driving unsafe, but seven of the twenty-five AD subjects were rated 
by collaterals as unsafe. Discrepancies between subject and collateral report 
about driving information (such as whether or not the subject was a safe 
driver or the number of driving infractions incurred) revealed a 
statistically significant difference between the groups, with AD subjects 
showing eleven discrepancies with their collaterals and controls showing 
only two discrepancies with their collaterals ( x 2(l)=8.25, jl<0.01). Likewise,
significant differences were shown in driving speed between the groups 
with seven subjects in the AD group indicating that they drive below the 
speed limit, while none of the controls made this claim. (See Table 6.)
A one-tailed t-test was used to compare the Total Driving Index of the 
two groups, with a significant differences found at the p=0.10 level 
(t(48)=1.36). Also, a one-tailed t-test was performed on the Corrected TDI, 
showing a significant difference between the groups at the p=0.07 level 
(t(48)= 1.54). Similarly, t-tests were performed on the factors comprising the 
Total Driving Index (Times Lost, Near Misses, Tickets, and Crashes), and there 
were no significant differences found between the groups for these factors. 
(See Table 7).
Discrepancies between the groups for estimated and actual scores on 
the DPT and DRI were assessed by use of t-tests. It was a matter of concern
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Table 5
Summary of Hierarchical Regression Analysis for Predictors of Total Driving 
Index With Correction for Miles Driven
V ariab le  B value Standard Error B value P.
For AD Subjects:
MMSE0.15 0.14 0.30 0.32
LM1 0.24 0.13 0.68 0.09
LM2 -0.20 0.13 -0.49 0.15
VR1 0.05 0.07 0.20 0.51
VR2 0.16 0.16 0.29 0.33
Trails A 0.03 0.10 0.49 0.02*
Trails B 0.00 0.00 0.05 0.84
BNT -0 .0 1 0.06 -0.06 0.88
Category Naming -0.13 0.12 -0.32 0.30
DPT -0.06 0.04 -0.35 0.14
DRI 0.20 0.10 0.37 0.06
For Control Subjects:
M M SE-0.10 0.20 -0.14 0.61
LM1 -0.12 0.11 -0.61 0.29
LM2 0.10 0.09 0.61 0.27
VR1 0.04 0.09 0.20 0.69
VR2 -0.07 0.02 -0.54 0.01**
Trails A -0.01 0.02 -0.17 0.58
Trails B 0.01 0.01 0.16 0.68
BNT 0.06 0.13 0.13 0.66
Category Naming -0.02 0.08 -0.14 0.69
DPT 0.02 0.03 0.25 0.48
DRI 0.02 0.07 0.06 0.83
Significant at p<0.05 
Significant at p=0.01
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Table 6
Comparisons of Results of Neuropsychological Test Scores. Driving 
Measures, and Total Driving Index bv Group
AD






Trails A 82.48 (35.63)





DPT Total 10.532 (13.47)
DPT Search 19.44 (7.01)
DPT Identify 20.96 (5.13)
DPT Predict 19.40 (4.97)
DPT Decide 25.20 (4.92)





C on tro l
M ean _ .SD t R
28.28 (1.70) -6.58 <0.01
20.96 (6.62) -5.89 <0.01
15.28 (7.52) -5.73 <0.01
29.30 (6.61) -5.36 <0.01
22.04 (9 .15) -9.05 <0.01
48.92 (18.86) 4.16 <0.01
101.12 (37.90) 5.78 <0.01
55.52 (2.74) -5.25 <0.01
16.40 (5 .51) -3.82 <0.01
116.16 (15.54) -2.64 0.01
23.36 (5.03) -2.27 0.03
23.52 (5.32) -1.73 n .s.
19.52 (5 .72) -0.08 n.s.
26.40 (5 .78) -0.79 n.s.
23.28 (4 .29) -2.34 0.02
15.80 (4 .73) 2.24 0.03
0.60 (1 .22) 1.36 n .s.
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Table 7
Correlations _of Total Driving Index With Neuropsychological and Driving 
Measures With Correction for Miles Driven
AD Subjects Control Subjects
M easures C o rre la tio n p C o rre la tio n p
MMSE -0.18 .40 -0.21 .31
LM1 -0.09 .68 -0.30 .14
LM2 -0.06 .79 -0.17 .42
VR1 -0.17 .41 -0.44 .03*
VR2 0.18 .39 -0.37 .07
Trails A 0.27 .20 0.36 .08
Trails B 0.13 .55 0.36 .08
BNT -0.25 .23 -0 .0 1 .97
Category Fluency -0.22 .29 -0.36 .08
DPT -0.17 .41 -0.20 .33
DRI 0.29 .17 0.21 .31
* Significant at g<0.05
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Table 8
Comparisons of Frequencies of Driving Characteristics bv 
Kruskall Wallis One Wav Analysis of Variance
AD Subjects Control Subjects 
Rank Sum Rank Sum

























that scores considered as above and below the actual score could cancel the 
effects of both. Therefore, the absolute value of the difference scores were
used for the DPT (t(48)=-l.75, n.s.) and for the DRI (t(48)=-4.11, £<0.001), with 
control subjects estimating their performance on the DRI better than the AD 
subjects. Additionally, for each group, the DPT Total and DRI were regressed 
upon the neuropsychological measures (MMSE, LM I, LM II, VR I, VR II,
Trails A, Trails B, BNT, and Category Fluency). Among the AD subjects, none 
of the neuropsychological tests were significant predictors of the DRI. For 
AD subjects, LM II approached significance (£=0.08) as a predictor of the DPT 
Total. For control subjects, VR II was the only significant predictor (£=0.02) 
of the DRI, while for the DPT Total, LM I and VR II were significant 
predictors (£<0.001 and £=0.03, respectively).
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D iscussion
Support was provided for some of the proposed hypotheses.
Hypothesis 1 predicted that predictors of driving ability would be different 
for the two experimental groups. This was found to be true, but the specific 
tests hypothesized to be effective did not turn out to be supported. It was 
postulated that the statistically significant predicting variables for the AD 
subjects would be the MMSE, the DPT, the DRI, and Trails A and B.
Regression analysis found only Trails A and the DRI to be significant 
contributors to the variance for AD subjects. While the MMSE had been 
found to be a predictor of driving in previous studies (Rebok, Keyl, Bylsma, 
Blaustein, & Tune, 1994; Mitchell, Castleden, & Fanthome, 1995), other studies 
utilized this test only as a broad measure of dementia severity (Gilley et al., 
1991; Fitten, et al., 1995). While it would be expected to show some correlation 
with driving simply because it is a screening measure of dementia, factor 
analysis has shown that the MMSE is comprised of verbal functions, memory 
abilities, and construction with most of the score coming from verbal items 
(Morris et al., 1989). This emphasis on verbal functions and construction is 
not consistent with the skills needed for driving and may in part account for 
why the MMSE was not a significant predictor in this study. Another 
possible factor limiting the MMSE's predictive utility here is the relatively 
truncated range of MMSE scores among the mild AD patients studied here.
The DPT was also not a significant predictor. This test comprises questions 
regarding knowledge of driving, and many of the questions regarding the 
driving scenes could be answered without having seen the vignette (or 
without being able to remember the scene). Although not true for all the 
items, many represented retrieval of overleamed knowledge, developed
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from years of driving experience. This kind of overleamed material is often 
relatively preserved in AD patients (Beatty et al., 1994), which may explain 
the failure to observe significant predicting contributions for AD subjects. 
Trails B, a more complex version of Trails A. provides added assessment of 
cognitive flexibility and set shifting that may not be pertinent to the 
driving skills reflected in the Total Driving Index. However, Trails A, as the 
variable that accounted for the most incremental variance, assesses complex 
visual scanning with a component of motor speed and agility (Lezak, 1995). 
Performance can also reflect how the subject responds to a complex visual 
array, which is particularly salient in driving. It is therefore not 
surprising that Trails A is a significant predictor. The DRI, approaching
significance, provides driving situations for the subjects that require visual 
scanning, integration of different stimuli, and quick decisions as to the 
maneuvers performed that reflect the abilities that AD subjects find 
increasingly difficult to do.
For predicting controls' Total Driving Index, the only variable 
accounting for significant incremental variance was Delayed Visual 
Reproduction, which was an unexpected finding. However, visuospatial
abilities diminish with age, with older adults five times more likely to report 
problems in activities involving visual search, peripheral vision, and 
cluttered visual scenes (Ball & Owsley, 1993). A logical conclusion is that 
those elderly people who have better visuospatial skills should have fewer 
problems driving. One reason why delayed visual reproduction was 
significant (rather than immediate recall) could be that those controls who 
can recall visual arrays of stimuli may be better able to predict hazardous 
situations, because they can draw from past experience and not have to
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analyze similar situations anew each time. However, because there was 
such a large discrepancy between the number of miles driven for the two 
groups, a Corrected TDI was derived that controlled for this difference. New 
regression equations revealed, that for the AD group. Trails A still accounted 
for the most incremental variance, but the DRI was also a significant 
predictor for the Corrected TDI. For the control group, the only significant 
predictor was VR I. This change from VR II as the only predictor for 
controls on the TDI to VR I on the Corrected TDI is most likely due to the high 
correlation between these two tasks. For the Corrected TDI, VR I may reflect 
such abilities as being able to remember what someone has ju st seen as they 
visually scan their environment before crossing an intersection. This may 
be particularly important because, as noted before, many accidents take 
place at intersections, traffic lights, and when changing lanes.
It was also hypothesized that the Total Driving Index would correlate 
significantly with the driving measure scores as well as the results of the 
neuropsychological tests, but this did not occur. Nor did it occur when the 
Corrected TDI was used in analyses. This may be due to restriction of range, 
as the present study yielded scores for the Total Driving Index ranging from 
zero to seven. Had the patient sample been larger or the Total Driving Index 
higher for some individuals, significant correlations may have been found. 
Similarly, the lack of findings could result from poor reliability due to 
subjective ratings by collaterals. Although there were no significant 
differences between the groups for the Total Driving Index, this may also be 
accounted for in part by the fact that the controls drove more than twice as 
many miles per week as the AD subjects. In some cases reduction of mileage 
driven was due to pressure from their relatives, and in some cases it was due
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to the AD subjects' recognition that their driving was not as good as it had 
been before the onset of these symptoms, although only one AD subject said 
she was not a safe driver, and she attributed this to her poor vision rather 
than any change in her driving skills. However, as expected, the collaterals 
of AD subjects described the subjects as unsafe more than the collaterals of 
c o n tro ls .
In other aspects of driving, differences were not found between the 
groups. For example, there was no difference in the number of subjects who 
were taking medications, nor were there differences in the number per 
group that restricted their driving in some way, such as avoiding rush hour. 
This would seem to suggest that both groups try to minimize their exposure 
to hazardous situations.
In considering the test performance of subjects, control subjects
performed significantly better on all neuropsychological measures as 
predicted. This demonstrates that the two groups were indeed different, and 
that the lack of significance of some analyses are not due to overlap between 
the groups. On driving measures, a more complex pattern of differences 
emerged. Controls did score significantly higher on the DRI and the DPT 
total score. Subtests of the DPT showed significant differences between the
groups for the search and execute subtests only. The search subtest assesses
ability to search the driving environment for possible hazards while the
execute subtest evaluates the ability of the subject to choose appropriate 
actions in dangerous situations. These are the two subtests of the DPT that 
appear to be least reflective of overlearned material. This suggests that, for 
driving tests to be able to differentiate between control and AD subjects, they
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must emphasize the dynamic parts of driving, not the overlearned, rote 
a sp ec ts .
It was surprising to find that there were no differences between the 
groups for the Total Driving Index or for the factors comprising it, 
particularly in light of the fact that many of the AD subjects’ collaterals 
rated subjects as unsafe. Therefore, it seems as though the subjective rating 
must be based on more than the objective, measurable events chosen to 
represent the Total Driving Index in this study. It may be that, in an attempt 
to objectify the collaterals' opinions, assessment of the subtle qualities of the 
subjects’ driving was eliminated. Drivers can exhibit many unsafe 
behaviors that are not reflected in getting lost, having near misses, tickets, 
or crashes. This could include having difficulty staying in their driving 
lane or driving so slowly that other drivers perform risky maneuvers to pass 
them. Additionally, even if a person with AD should execute a dangerous 
action (such as changing lanes without looking), other drivers may be adept 
enough to avoid colliding with that individual. It may be then that to more 
fully understand the quality of someone's driving a check-list of risky 
behaviors should be developed to provide a more comprehensive picture of 
hazardous behaviors that could be performed. It could also be that the TDI 
was compromised by bias in the collateral ratings. This bias could arise from 
faulty memory on the part of the collateral, who was generally the spouse of 
the subject. The spouse may also have been biased by the transportation 
resources available. It would be likely that, if the patient was the only 
source o f transportation, the collateral may be more likely to deny problems 
that could affect the subject's driving status.
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Findings regarding estimated and actual performance on the DPT and 
DRI indicated no difference in rating of performance between the groups 
for the DPT, but, on the DRI, controls subjects were able to estimate their 
performance better than AD subjects. It may be that AD subjects show
efficacy similar to controls for their DPT estimates because they are basing
their estimate on what they were able to do in the past. As said before, it may 
be that the DPT is a better indicator of overleamed material than the DRI, 
which may reflect more the ability to judge situations in a more fluid
fashion. If this is the case, then the AD subjects’ estimate of DPT
performance could be more correctly surmised by using past standards of 
their driving to make estimates. However, the DRI would require more 
manipulation of information and judgment, requiring the AD participants to 
use skills they no longer have. By relying on evaluations of past abilities,
AD subjects would tend to overestimate their present performance and make 
inaccurate predictions.
In this study, the TDI was not sufficient to distinguish between the two 
groups. In an effort to better understand the relationship between driving 
and neuropsychological tests, predictors of the driving measures were 
considered. For AD subjects, there were no significant predictors for the
DRI, and only LM2 approached significance for the DPT. The lack of 
predictors for the DRI is not surprising; it is a reflection of the difficulties 
encountered by researchers in driving who are unable to find predictors of 
driving that are significant across studies. This highlights the fact that 
driving consists of many cognitive factors that cannot be easily assessed by 
our current neuropsychological measures. It is interesting that LM2
approached significance as a predictor of DPT, since this test was
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hypothesized to be indicative of crystallized knowledge of driving and its 
"rules," accumulated over years of experience. This is consistent with the 
long-term memory abilities assessed by LM2. For controls, the DRI 's only 
significant predictor was VR2, which is congruent with the premise
discussed above that the more "fluid” aspects o f driving are enhanced by the
ability to remember other similar situations in the past and to benefit from 
the knowledge gained by them. For control subjects, predictors of the DPT 
Total were LM1 and VR2, which again emphasizes the importance of both 
verbal and visual memory for adequate knowledge of the "overlearned"
aspects of driving.
In conclusion, these findings suggest that the best predictors of 
driving for both groups are visuospatial measures, requiring visual 
scanning, a motor response to a visual stimulus, and identification of salient
visual material in a timely manner. Although predictors were different for
both groups, it is evident that neuropsychological tests that are not
visuospatially oriented did not predict driving ability as measured by the
Total Driving Index. Although the two groups were similar in many 
characteristics of driving, AD subjects were shown to drive fewer miles and 
tend to drive slower as if to compensate for deficits, although most felt that 
they were safe drivers. Future studies should try to develop a better and 
more comprehensive criterion variable than the TDI used here - one that 
reflects more subtle evidence of risky driving than just the objective 
measures used here. Considering the number of AD subjects' collaterals who 
reported the subject was unsafe, it is obvious that more characteristics of
dangerous driving need to be evaluated to provide a clear picture of the 
deficits in driving that these subjects show.
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More research needs to be done to provide more sensitive measures of 
driving ability. Apparently some AD patients do have the knowledge and
driving skills to permit them to safely drive familiar routes occasionally.
But tests need to be devised to ascertain if they have the visuospatial skills, 
reaction time, and judgment to stop in an emergency situation. It is these 
uncommon, novel, and emergency situations that provide the most danger 
for AD patients and for others on the road.
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